Wave Life Sciences WVE Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $38.25M— | —— | —— | $8.7M-5.2% | $9.18M— | ||
| $47.44M-10.2% | $52.81M+15.1% | $45.87M+5.5% | $43.47M+7.0% | $40.62M-9.0% | ||
| $22.1M+5.8% | $20.9M+15.5% | $18.09M+0.5% | $17.99M-2.0% | $18.36M+13.8% | ||
| $69.54M-5.7% | $73.71M+15.2% | $63.96M+4.1% | $61.46M+4.2% | $58.98M-3.0% | ||
| -$31.3M+44.6% | -$56.47M-0.2% | -$56.35M-6.8% | -$52.76M-5.9% | -$49.8M— | ||
| -81.8%— | —— | —— | -606.5%-63.7pp | -542.8%— | ||
| $5.21M+58.5% | $3.29M+31.5% | $2.5M+9.2% | $2.29M-21.7% | $2.93M-53.5% | ||
| -$26.09M+50.9% | -$53.18M+1.2% | -$53.85M-6.7% | -$50.47M-7.7% | -$46.88M— | ||
| $0— | -$0— | $0— | $0— | $0— | ||
| -$26.09M+50.9% | -$53.18M+1.2% | -$53.85M-6.7% | -$50.47M-7.7% | -$46.88M— | ||
| -68.2%— | —— | —— | -580.2%-69.2pp | -510.9%— | ||
| -$0.13+55.2% | -$0.29+9.4% | -$0.32-3.2% | -$0.31-6.9% | -$0.29— | ||
| -$30.46M+45.2% | -$55.62M-0.2% | -$55.5M-6.9% | -$51.89M-6.1% | -$48.93M— | ||
| -79.6%— | —— | —— | -596.6%-63.3pp | -533.3%— | ||
| -$31.3M+44.6% | -$56.47M-0.2% | -$56.35M-6.8% | -$52.76M-5.9% | -$49.8M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Wave Life Sciences's revenue?
- Wave Life Sciences (WVE) generated $75.8M in revenue over the trailing twelve months, down 32.9% year over year.
- Is Wave Life Sciences profitable?
- Wave Life Sciences is not currently profitable: it reported a net loss of $183.6M over the trailing twelve months, a -66.5% net margin.
- What is Wave Life Sciences's earnings per share?
- Wave Life Sciences's diluted EPS over the trailing twelve months is $-1.05.
- Where does Wave Life Sciences's income statement data come from?
- Every line is extracted from Wave Life Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
